128 related articles for article (PubMed ID: 9831386)
1. A sandwich type acridinium-linked immunosorbent assay (ALISA) detects soluble ErbB1 (sErbB1) in normal human sera.
Baron AT; Lafky JM; Connolly DC; Peoples J; O'Kane DJ; Suman VJ; Boardman CH; Podratz KC; Maihle NJ
J Immunol Methods; 1998 Oct; 219(1-2):23-43. PubMed ID: 9831386
[TBL] [Abstract][Full Text] [Related]
2. Serum sErbB1 and epidermal growth factor levels as tumor biomarkers in women with stage III or IV epithelial ovarian cancer.
Baron AT; Lafky JM; Boardman CH; Balasubramaniam S; Suman VJ; Podratz KC; Maihle NJ
Cancer Epidemiol Biomarkers Prev; 1999 Feb; 8(2):129-37. PubMed ID: 10067810
[TBL] [Abstract][Full Text] [Related]
3. A preliminary study of serum concentrations of soluble epidermal growth factor receptor (sErbB1), gonadotropins, and steroid hormones in healthy men and women.
Baron AT; Lafky JM; Suman VJ; Hillman DW; Buenafe MC; Boardman CH; Podratz KC; Perez EA; Maihle NJ
Cancer Epidemiol Biomarkers Prev; 2001 Nov; 10(11):1175-85. PubMed ID: 11700266
[TBL] [Abstract][Full Text] [Related]
4. Soluble epidermal growth factor receptor acridinium-linked immunosorbent assay.
Lafky JM; Baron AT; Maihle NJ
Methods Mol Biol; 2006; 327():39-47. PubMed ID: 16780211
[TBL] [Abstract][Full Text] [Related]
5. Monoclonal antibodies specific for peptide epitopes of the epidermal growth factor receptor's extracellular domain.
Baron AT; Huntley BK; Lafky JM; Reiter JL; Liebenow J; McCormick DJ; Ziesmer SC; Roche PC; Maihle NJ
Hybridoma; 1997 Jun; 16(3):259-71. PubMed ID: 9219036
[TBL] [Abstract][Full Text] [Related]
6. Soluble epidermal growth factor receptor (sEGFR/sErbB1) as a potential risk, screening, and diagnostic serum biomarker of epithelial ovarian cancer.
Baron AT; Cora EM; Lafky JM; Boardman CH; Buenafe MC; Rademaker A; Liu D; Fishman DA; Podratz KC; Maihle NJ
Cancer Epidemiol Biomarkers Prev; 2003 Feb; 12(2):103-13. PubMed ID: 12582019
[TBL] [Abstract][Full Text] [Related]
7. ErbBs inhibition by lapatinib blocks tumor growth in an orthotopic model of human testicular germ cell tumor.
Juliachs M; Castillo-Ávila W; Vidal A; Piulats JM; Garcia Del Muro X; Condom E; Hernández-Losa J; Teixidó C; Pandiella A; Graupera M; Casanovas O; Germà JR; Villanueva A; Viñals F
Int J Cancer; 2013 Jul; 133(1):235-46. PubMed ID: 23292912
[TBL] [Abstract][Full Text] [Related]
8. Quantification and detection of DcR3, a decoy receptor in TNFR family.
Chen J; Zhang L; Kim S
J Immunol Methods; 2004 Feb; 285(1):63-70. PubMed ID: 14871535
[TBL] [Abstract][Full Text] [Related]
9. Elevated soluble c-erbB-2 antigen levels in the serum and effusions of a proportion of breast cancer patients.
Leitzel K; Teramoto Y; Sampson E; Mauceri J; Langton BC; Demers L; Podczaski E; Harvey H; Shambaugh S; Volas G
J Clin Oncol; 1992 Sep; 10(9):1436-43. PubMed ID: 1355522
[TBL] [Abstract][Full Text] [Related]
10. ErbB receptors and fatty acid synthase expression in aggressive head and neck squamous cell carcinomas.
Silva SD; Cunha IW; Younes RN; Soares FA; Kowalski LP; Graner E
Oral Dis; 2010 Nov; 16(8):774-80. PubMed ID: 20604875
[TBL] [Abstract][Full Text] [Related]
11. Prognostic value of ERBB family mRNA expression in breast carcinomas.
Bièche I; Onody P; Tozlu S; Driouch K; Vidaud M; Lidereau R
Int J Cancer; 2003 Sep; 106(5):758-65. PubMed ID: 12866037
[TBL] [Abstract][Full Text] [Related]
12. Dual inhibition of ErbB1 and ErbB2 in cancer by recombinant human prolidase mutant hPEPD-G278D.
Yang L; Li Y; Bhattacharya A; Zhang Y
Oncotarget; 2016 Jul; 7(27):42340-42352. PubMed ID: 27286447
[TBL] [Abstract][Full Text] [Related]
13. Cross-reactivity of C219 anti-p170(mdr-1) antibody with p185(c-erbB2) in breast cancer cells: cautions on evaluating p170(mdr-1).
Liu B; Sun D; Xia W; Hung MC; Yu D
J Natl Cancer Inst; 1997 Oct; 89(20):1524-9. PubMed ID: 9337349
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of Protein Levels of the Receptor Tyrosine Kinase ErbB3 in Serum.
D'Abronzo LS; Pan CX; Ghosh PM
Methods Mol Biol; 2018; 1655():319-334. PubMed ID: 28889394
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of a competitive enzyme-linked immunosorbent assay for measurements of soluble HLA-G protein.
Rasmussen M; Dahl M; Buus S; Djurisic S; Ohlsson J; Hviid TV
Tissue Antigens; 2014 Aug; 84(2):206-15. PubMed ID: 24785939
[TBL] [Abstract][Full Text] [Related]
16. Clinical implementation of soluble EGFR (sEGFR) as a theragnostic serum biomarker of breast, lung and ovarian cancer.
Baron AT; Wilken JA; Haggstrom DE; Goodrich ST; Maihle NJ
IDrugs; 2009 May; 12(5):302-8. PubMed ID: 19431095
[TBL] [Abstract][Full Text] [Related]
17. Transactivation of ErbB1 and ErbB2 receptors by angiotensin II in normal human prostate stromal cells.
Lin J; Freeman MR
Prostate; 2003 Jan; 54(1):1-7. PubMed ID: 12481249
[TBL] [Abstract][Full Text] [Related]
18. Differential utilization and localization of ErbB receptor tyrosine kinases in skin compared to normal and malignant keratinocytes.
Stoll SW; Kansra S; Peshick S; Fry DW; Leopold WR; Wiesen JF; Sibilia M; Zhang T; Werb Z; Derynck R; Wagner EF; Elder JT
Neoplasia; 2001; 3(4):339-50. PubMed ID: 11571634
[TBL] [Abstract][Full Text] [Related]
19. An Aptamer Linked Immobilized Sorbent Assay (ALISA) to Detect Circulatory IFN-α, an Inflammatory Protein among Tuberculosis Patients.
Taneja V; Goel M; Shankar U; Kumar A; Khilnani GC; Prasad HK; Prasad GBKS; Gupta UD; Sharma TK
ACS Comb Sci; 2020 Nov; 22(11):656-666. PubMed ID: 33063508
[TBL] [Abstract][Full Text] [Related]
20. The extracellular region of ErbB4 adopts a tethered conformation in the absence of ligand.
Bouyain S; Longo PA; Li S; Ferguson KM; Leahy DJ
Proc Natl Acad Sci U S A; 2005 Oct; 102(42):15024-9. PubMed ID: 16203964
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]